- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 31/16 - Amides, p. ex. acides hydroxamiques
Détention brevets de la classe A61K 31/16
Brevets de cette classe: 2564
Historique des publications depuis 10 ans
|
155
|
147
|
153
|
154
|
144
|
123
|
134
|
126
|
105
|
10
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The William M. Yarbrough Foundation | 92 |
33 |
| The Regents of the University of California | 20355 |
27 |
| Nacuity Pharmaceuticals, Inc. | 43 |
26 |
| SK Biopharmaceuticals Co., Ltd. | 270 |
21 |
| The Johns Hopkins University | 5772 |
17 |
| The Board of Trustees of the Leland Stanford Junior University | 6594 |
16 |
| Merck Sharp & Dohme Corp. | 2186 |
15 |
| Allergan, Inc. | 2282 |
15 |
| Praxis Precision Medicines, Inc. | 204 |
15 |
| The General Hospital Corporation | 4793 |
14 |
| Novartis AG | 10494 |
11 |
| The Regents of the University of Michigan | 4836 |
11 |
| Synta Pharmaceuticals Corp. | 159 |
11 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3240 |
11 |
| SpringWorks Therapeutics, Inc. | 153 |
11 |
| F. Hoffmann-La Roche AG | 7893 |
10 |
| Board of Regents, The University of Texas System | 5989 |
10 |
| The Trustees of Columbia University in the City of New York | 3616 |
10 |
| Takeda Pharmaceuticals U.S.A., Inc. | 212 |
10 |
| President and Fellows of Harvard College | 6049 |
9 |
| Autres propriétaires | 2261 |